Ademuyiwa S. Aromolaran

Ademuyiwa S. Aromolaran, FAHA, FHRS, PhD

Languages spoken: English

Academic Information

Departments Primary - Surgery , , Adjunct - Biochemistry

Divisions: Cardiothoracic Surgery

Academic Office Information

Ademuyiwa.Aromolaran@hsc.utah.edu

Education History

Graduate Training Massachusetts College of Pharmacy and Health Sciences
 Graduate Certificate
Research Fellow Loyola University Medical Center
 Research Fellow
Research Fellow Loyola University Medical Center
 Research Fellow
Doctoral Training St George's, University of London
 PhD
Graduate Training King's College London
 MSc
Undergraduate University of Ibadan
 BSc

Selected Publications

Journal Article

  1. Bernardi J, Aromolaran KA, Zhu H, Aromolaran AS (2021). Circadian Mechanisms: Cardiac Ion Channel Remodeling and Arrhythmias. Front Physiol, 11, 611860. (Read full article)
  2. Bernardi J, Aromolaran KA, Aromolaran AS (2020). Neurological Disorders and Risk of Arrhythmia. Int J Mol Sci, 22(1). (Read full article)
  3. Aromolaran AS (2019). Mechanisms of electrical remodeling in lipotoxic guinea pig heart. Biochem Biophys Res Commun, 519(3), 639-644. (Read full article)
  4. Martinez-Mateu L, Saiz J, Aromolaran AS (2019). Differential Modulation of IK and ICa,L Channels in High-Fat Diet-Induced Obese Guinea Pig Atria. Front Physiol, 10, 1212. (Read full article)
  5. Boutjdir M, Aromolaran AS, de Las Fuentes L, Boyington JEA, Arteaga SS, Jobe J, Jeffe DB, Rao DC, Rice TK, Davila-Roman VG (2018). Research Education and Mentoring Program in Cardiovascular Diseases for Under-Represented Junior Faculty From NHLBI SIPID/PRIDE. J Am Coll Cardiol, 73(14), 1861-1865. (Read full article)
  6. Al A, Boutjdir M, Aromolaran AS (2019). Cardiolipotoxicity, Inflammation, and Arrhythmias: Role for Interleukin-6 Molecular Mechanisms. Front Physiol, 9, 1866. (Read full article)
  7. Aromolaran AS, Srivastava U, Al A, Chahine M, Lazaro D, El-Sherif N, Capecchi PL, Laghi-Pasini F, Lazzerini PE, Boutjdir M (2018). Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation. PLoS One, 13(12), e0208321. (Read full article)
  8. Aromolaran AS, Chahine M, Boutjdir M (2017). Regulation of Cardiac Voltage-Gated Sodium Channel by Kinases: Roles of Protein Kinases A and C. Handb Exp Pharmacol, 246, 161-184. (Read full article)
  9. Lazzerini PE, Laghi-Pasini F, Bertolozzi I, Morozzi G, Lorenzini S, Simpatico A, Selvi E, Bacarelli MR, Finizola F, Vanni F, Lazaro D, Aromolaran A, El Sherif N, Boutjdir M, Capecchi PL (2017). Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes. Heart, 103(22), 1821-1829. (Read full article)
  10. Aromolaran AS, Boutjdir M (2017). Cardiac Ion Channel Regulation in Obesity and the Metabolic Syndrome: Relevance to Long QT Syndrome and Atrial Fibrillation. Front Physiol, 8, 431. (Read full article)
  11. Srivastava U, Aromolaran AS, Fabris F, Lazaro D, Kassotis J, Qu Y, Boutjdir M (2016). Novel function of α1D L-type calcium channel in the atria. Biochem Biophys Res Commun, 482(4), 771-776. (Read full article)
  12. Aromolaran AS, Colecraft HM, Boutjdir M (2016). High-fat diet-dependent modulation of the delayed rectifier K(+) current in adult guinea pig atrial myocytes. Biochem Biophys Res Commun, 474(3), 554-559. (Read full article)
  13. Puckerin A, Aromolaran KA, Chang DD, Zukin RS, Colecraft HM, Boutjdir M, Aromolaran AS (2016). hERG 1a LQT2 C-terminus truncation mutants display hERG 1b-dependent dominant negative mechanisms. Heart Rhythm, 13(5), 1121-1130. (Read full article)
  14. Aromolaran AS, Subramanyam P, Chang DD, Kobertz WR, Colecraft HM (2014). LQT1 mutations in KCNQ1 C-terminus assembly domain suppress IKs using different mechanisms. Cardiovasc Res, 104(3), 501-11. (Read full article)
  15. Rong YP, Bultynck G, Aromolaran AS, Zhong F, Parys JB, De Smedt H, Mignery GA, Roderick HL, Bootman MD, Distelhorst CW (2009). The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor. Proc Natl Acad Sci U S A, 106(34), 14397-402. (Read full article)
  16. Rong YP, Aromolaran AS, Bultynck G, Zhong F, Li X, McColl K, Matsuyama S, Herlitze S, Roderick HL, Bootman MD, Mignery GA, Parys JB, De Smedt H, Distelhorst CW (2007). Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals. Mol Cell, 31(2), 255-65. (Read full article)
  17. Aromolaran AS, Zima AV, Blatter LA (2007). Role of glycolytically generated ATP for CaMKII-mediated regulation of intracellular Ca2+ signaling in bovine vascular endothelial cells. Am J Physiol Cell Physiol, 293(1), C106-18. (Read full article)
  18. Snopko RM, Aromolaran AS, Karko KL, Ramos-Franco J, Blatter LA, Meja-Alvarez R (2006). Cell culture modifies Ca2+ signaling during excitation-contraction coupling in neonate cardiac myocytes. Cell Calcium, 41(1), 13-25. (Read full article)
  19. Aromolaran AA, Blatter LA (2005). Modulation of intracellular Ca2+ release and capacitative Ca2+ entry by CaMKII inhibitors in bovine vascular endothelial cells. Am J Physiol Cell Physiol, 289(6), C1426-36. (Read full article)
  20. Albert AP, Aromolaran AS, Large WA (2001). Agents that increase tyrosine phosphorylation activate a non-selective cation current in single rabbit portal vein smooth muscle cells. J Physiol, 530(Pt 2), 207-17. (Read full article)
  21. Aromolaran AS, Albert AP, Large WA (2000). Evidence for myosin light chain kinase mediating noradrenaline-evoked cation current in rabbit portal vein myocytes. J Physiol, 524 Pt 3, 853-63. (Read full article)
  22. Aromolaran AS, Large WA (1999). Comparison of the effects of divalent cations on the noradrenaline-evoked cation current in rabbit portal vein smooth muscle cells. J Physiol, 520 Pt 3, 771-82. (Read full article)

Editorial

  1. Morrow JP, Akar FG, Aromolaran AS (2019). Editorial: Arrhythmogenic Substrates in Diabetes and Obesity. Front Physiol, 10, 549. (Read full article)